Market: CGM to $25B

The global blood‑glucose‑monitoring market is projected to hit $25.41 billion by 2030, driven largely by CGMs and connected devices — and the pen‑needles market is forecast to reach $8.5 billion by 2031. (openpr.com) (openpr.com)